Oral care giant Colgate-Palmolive has entered into a partnership with pharmaceutical company Klox Technologies in a bid to further its oral health technology reach.
The partnership will see Colgate-Palmolive globally commercialize Klox Technologies proprietary biophotonic technology in the oral health market through a worldwide licence, and make an equity investment in the company.
According to Suzan Harrison, President of Global Oral Care for Colgate-Palmolive the agreement will help develop the market. She says, “We are very pleased to have Klox as a partner in the development of this exciting and new technology platform for the benefit of oral health.”
Dr. Lise Hébert, president and CEO of Klox, said, “We are extremely pleased to have Colgate-Palmolive, the leader in oral care, with activities in over 200 countries and territories, be our global partner for our oral health platform. These agreements once again recognize the breadth of our technology platform. Furthermore, these agreements validate the value creation strategy we have adopted by partnering large potential indications with first in class partners, while building a specialized sales force for products within wound care.”